Ravinder Singh

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Combination Therapy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Julien Hadoux, Rossella Elisei, Marcia S Brose, Ana O Hoff, Bruce G Robinson, Ming Gao, Barbara Jarzab, Pavel Isaev, Katerina Kopeckova, Jonathan Wadsley, Dagmar Führer, Bhumsuk Keam, Stéphane Bardet, Eric J Sherman, Makoto Tahara, Mimi I Hu, Ravinder Singh, Yan Lin, Victoria Soldatenkova, Jennifer Wright, Boris Lin, Patricia Maeda, Jaume Capdevila, Lori J Wirth, null null
Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer. The New England journal of medicine (2023)